The consequences of DNA damage depend on the cell type and the severity of the damage. Mild DNA damage can be repaired with or without cell-cycle arrest. More severe and irreparable DNA injury leads to the appearance of cells that carry mutations or causes a shift towards induction of the senescence or cell death programs. Although for many years it was argued that DNA damage kills cells via apoptosis or necrosis, technical and methodological progress during the last few years has helped to reveal that this injury might also activate death by autophagy or mitotic catastrophe, which may then be followed by apoptosis or necrosis. The molecular basis underlying the decision-making process is currently the subject of intense investigation. Here, we review current knowledge about the response to DNA damage and subsequent signaling, with particular attention to cell death induction and the molecular switches between different cell death modalities following damage.
INTRODUCTION
Genomic integrity and stability is constantly threatened by DNA damage, which may arise from numerous environmental and intrinsic sources. Failure to repair DNA damage can cause mutations, genomic instability, premature aging, mental multiplex retardation and other developmental disorders as well as cancer. Consequently, eukaryotes have evolved a complex set of mechanisms to sense different types of DNA damage and safeguard the genome, the so-called DNA damage response (DDR). The DDR comprises a multiple networks of signal transduction pathways initiated by sensing damage, followed by signal transmission to effectors through activation of a cascade of phosphorylation events. A group of proteins, including mediator of DNA damage checkpoint protein 1 (Chk1; MDC1/NFBD1), 53BP1 (p53-binding protein 1), the Mre11-Rad50-NBS1 (MRN) and the Rad9-Rad1-Hus1 (9-1-1) complexes, have been implicated as DNA damage sensors and recognize both double-and single-strand breaks (DSBs and SSBs, respectively) as well as regions of replication stress. [1] [2] [3] [4] Binding of the MRN and 9-1-1 complexes to the sites of DNA damage in chromatin activates the signal transducing kinase ataxia-telangiectasia mutated (ATM), the ATM and Rad3-related (ATR) kinase and the DNA-dependent protein kinase (DNA-PK). Once activated, ATR and ATM amplify the damage signal by phosphorylating various substrates, including key DDR proteins H2AX, BRCA1, NBS1, SMC1 (structural maintenance of chromosome protein 1), MDC1 and 53BP1, as well as repair proteins Ku70/80, Artemis and Rad-like proteins. 5, 6 Additionally, in order to allow time for DNA repair, ATM temporarily arrests the cell cycle by phosphorylation and activation of cell-cycle checkpoints. p53, as one of the main targets of ATM/ATR, is a universal sensor of genotoxic stress and has a key role in cellular responses to DNA damage, determining the fate of cells towards either survival, which involves cell-cycle delay accompanied by repair of DNA damage, or cell death. 7 Depending on the cell type and the severity and extent of DNA damage, the activated DDR can elicit different cellular responses ( Figure 1 ). Mild DNA damage normally leads to the induction of cell-cycle arrest, whereas severe and irreparable injury shifts the cellular response towards induction of the senescence or cell death programs, such as apoptosis, mitotic catastrophe (MC), autophagy and necrosis. The molecular basis underlying the decision-making process is currently the subject of intense investigation. Here, we review current knowledge about the DDR with particular attention to cell death induction and the molecular switches between different cell death modalities following DNA damage.
CELL SENESCENCE IN RESPONSE TO DNA DAMAGE
Cellular senescence is one of the consequences of severe or irreparable DNA damage, especially DNA DSBs, and it is characterized by an irreversible growth arrest of cells in the G1 phase. Cellular senescence limits the proliferation of DNAdamaged cells that are at risk of neoplastic transformation. However, these cells remain metabolically active, showing a greatly altered pattern of gene expression. The outcomes of cellular senescence following DNA damage are highly dependent on the cell type and physiological context. Cells of epithelial and stromal origin undergo senescence following severe DNA damage, while lymphoid cells undergo apoptosis. In most cell types, activation of p53 is crucial for initiating the senescence response following DNA damage, and in certain cells p53 is also important for maintaining the senescent growth arrest. p21 waf1/cip1 , as a crucial target of p53 and mediator of senescence, inhibits a spectrum of cyclin-dependent kinases that regulate the phosphorylation of the retinoblastoma protein (pRb). The hypophosphorylated form of pRb binds to the transcription factor E2F, leading to transactivation of the genes essential for the G1-to-S transition. On the other hand, p21 can mediate transient DNA damage-induced growth arrest. It is still unclear what determines whether cells senesce or arrest transiently. It is likely that rapid DNA repair will quickly shut down p53-p21 signaling, whereas incomplete or incorrect repair results in prolonged signaling and senescence.
Stimuli that produce DDR can also engage the p16-pRb pathway. It was shown that in the terminal stages of growth arrest in the senescence of human diploid fibroblasts, the p16 mRNA and cellular protein levels were upregulated almost 40-fold. p16 was also shown to be complexed to CDK4 (cyclin-dependent kinase 4) and CDK6 and is the major inhibitor of both kinases.
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Although both p16 and p21 are CDK inhibitors, they are not equivalent. Cells that undergo senescence solely due to activation of p53-p21 can restart growth after inactivation of the p53 pathway. However, cells that fully engage the p16-pRb pathway cannot resume growth even after inactivation of p53, pRb or p16. 12 Thus, both of these pathways can cause transient or reversible cell-cycle arrest, and it remains to be clarified exactly how their activities are modified by senescence-inducing signals and how cells make decisions in response to damage signals.
Both events, senescence and apoptosis, are under the control of p53; therefore, it is difficult to understand the switch between these two modes of cellular response upon DNA damage-induced activation of p53. It seems that normal cells, in which all signaling pathways are intact, have a preference toward senescence compared with transformed cells and that senescence is usually induced by lower levels of damage than those leading to apoptosis. 13 Overall, p53 stands at the center of a complex signal transduction pathway following DNA damage. Phosphorylation of p53 at Ser15, Thr18 and Ser376 and dephosphorylation at Ser392 has been detected in fibroblasts undergoing senescence.
14 By contrast, phosphorylation at Ser46 was shown to be associated with the induction of p53AIP1 (p53-regulated apoptosis-inducing protein 1) and apoptosis. A study on MCF-7 cells demonstrated the role of different phosphorylation sites (Ser15 and Ser46), induction of p21 and high or low reactive oxygen species (ROS) levels in determining the dosage of adriamycin that induced either apoptosis or senescence. Cells in these two states exhibited quite distinct time course profiles of the proteins p53, p21 and E2F1. As mentioned above, DNA damage can also activate Rb through the p16 pathway to induce senescence. An in vivo study showed that, following cyclophosphamide treatment, a p53-dependent effect can also occur in an apoptosis-independent fashion by inducing cellular senescence in a p53-and p16-dependent manner. 15 Thus, the genetic context, cell type or the specific activation of certain target genes upon DNA damage can favor either senescence or apoptosis.
APOPTOSIS AS A FAST-ACTING RESPONSE TO DNA DAMAGE Like cellular senescence, apoptosis is activated in response to cellular stress and is executed when repair of DNA damage is slow or incomplete. As mentioned above, it is still not fully understood how cells decide whether to undergo senescence or apoptosis, and despite the fact that most cells are capable of both, these processes seem to be mutually exclusive. Numerous studies have clearly shown cross-talk between the processes of apoptosis and senescence, primarily at the level of p53, which is considered to be a major player in the apoptotic response to genotoxins. The phosphorylation of p53 at Ser46 is the most prominent in priming its apoptotic activity. 16 Subsequently, homeodomain-interacting protein kinase 2 (HIPK2), a serine/threonine nuclear kinase, was identified as the p53 Ser46 kinase. 17, 18 Following severe damage, HIPK2 binds p53 and is recruited to promyelocytic leukemia protein (PML) nuclear bodies, where PML acts as the main cofactor for efficient HIPK2-mediated p53 phosphorylation. HIPK2-mediated p53 Ser46 phosphorylation leads to enhanced acetylation (Lys382) of p53 by the CREB-binding protein, which also interacts with HIPK2 and colocalizes in PML nuclear bodies. The latter results in complete transcriptional activation of p53 followed by potentiation of pro-apoptotic target gene expression. 17, 18 p53 can upregulate PML expression, thus potentiating the apoptotic signal. Depending on the extent of DNA damage, p53 itself can either potentiate HIPK2 activity or negatively regulate HIPK2 stability. 19, 20 Following activation, p53 initiates expression of its apoptotic target genes, such as p53-upregulated modulator of apoptosis (PUMA), p53AIP1, Bax and apoptotic protease activating factor 1 (Apaf-1), in this way regulating the intrinsic apoptotic pathway. Upon DNA damage, p53 also promotes the extrinsic apoptotic pathway through upregulation of the TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptors, death receptor-4 and death receptor-5 (KILLER), as well as the CD95 receptor (Fas/Apo-1) and the CD95 (Fas/Apo-1) ligand. 21 Recently an orphan nuclear receptor, ROR a , was identified as a direct target gene of p53. Upon DNA damage, ROR a stabilizes p53 and activates p53 transcription, leading to the activation of a subset of p53 target genes that are specifically involved in apoptosis. 22 It has also been discovered that DNA damage activates p53-dependent expression of specific microRNAs (miRNAs), which carry pro-apoptotic functions. The examination of miRNA Figure 1 . DNA damage response. DNA damage results from multiple environmental and intrinsic sources, activating a complex set of reactions called DNA damage response. This response is initiated by damage detection, followed by signal transmission to effectors and finally results in a number of cellular responses, such as induction of cell-cycle arrest, repair of the lesions or, in case of non-repairable damage, leads to activation of cell death program. A group of proteins, including Mre11-Rad50-NBS1 (MRN complex) and the Rad9-Rad1-Hus1 (9-1-1) complex, fulfilling a function of DNA damage sensors, and recognized both DSBs and SSBs. Binding of the MRN and 9-1-1 complexes to the sites of DNA damage in chromatin activates the signal transducing kinase ATM, preferentially in response to DSBs and the disruption of chromatin structure. By contrast, the ATR kinase is activating primarily in response to SSBs and replication forks. The activation of DNA repair (orchestrated by set of DNA damage response proteins, including BRCA1, NBS1, as well as repair proteins Ku70/80 and others) and cell-cycle checkpoints (regulated by MDC1, 53BP1 and checkpoint kinases Chk1/Chk2) act as an immediate response to DNA damage to provide protection and recovery of injured cells, whereas activation of cell death occurs much later and aims to eliminate the irreversibly damaged cell. Depending on type and the severity of stimulus and cellular context, DNA damage can induce different cell death programs, such as mitotic catastrophe, apoptosis, autophagy and necrosis.
expression profiles in wild-type and p53-deficient mouse embryonic fibroblasts (MEFs) revealed that p53 affects the expression of 145 mouse miRNAs. These p53-induced miRNAs may amplify the pro-apoptotic signals by targeting a network of existing transcripts in response to DNA damage. As an example, p53 can induce the expression of miRNA-34a (miR-34a) in cultured H1299 lung cancer cells as well as in irradiated mice. Markedly, inactivation of miR34a strongly attenuates p53-mediated apoptosis in cells exposed to genotoxic stress, whereas overexpression of miR-34a mildly increases apoptosis. 23, 24 Although p53 primarily acts as a nuclear transcription factor, it has also been shown to contribute to apoptosis induction in the cytoplasm by transcription-independent mechanisms. p53 was found to translocate to the cytoplasm in response to different stress signals where it stimulates mitochondrial outer membrane permeabilization and caspase activation, as well as antagonizes the anti-apoptotic proteins Bcl-2 and Bcl-X L by their direct binding. 25 In addition to p53, its homologs p73 and p63 are involved in apoptotic responses upon DNA damage. Following etoposide-induced DNA damage, Chk1 and Chk2 are activated by ATM and/or ATR, which leads to activation of the p73 transcription factor E2F1, followed by increased levels of p73 protein. Although the combined absence of p63 and p73 was shown to severely impair the induction of p53-dependent apoptosis in response to DNA damage, p73 can be pro-apoptotic itself even in the absence of p53.
26 p73 elicits apoptosis via the mitochondrial pathway using PUMA and Bax as mediators, followed by the release of cytochrome c. Moreover, p73 shares many pro-apoptotic target genes with p53, such as Noxa, Caspase-6 and CD95. Interestingly, p73 is also a substrate for caspases, and after processing its truncated version, localizes to the mitochondria and amplifies apoptosis in response to TRAIL. 27 The cytoplasmic functions of p73 remain to be investigated.
Another p53-independent mechanism that can be engaged upon DNA damage implicates the protein Nur77, also known as TR3 or NGFI-B (nerve growth factor IB). Similarly to p53, the pro-apoptotic action of Nur77 is believed to be exerted through its nuclear transactivation of gene expression. Accumulating data suggest that translocation of Nur77 from the nucleus to the mitochondria represents an important mechanism by which Nur77 initiates apoptosis. In response to differential apoptotic stimuli, Nur77 migrates from the nucleus to the cytoplasm where it targets mitochondria, which is associated with the release of cytochrome c and induction of apoptosis. 28 However, recent studies showed the ability of Nur77 to inhibit apoptosis. When overexpressed in HEK293 cells, Nur77 promotes resistance to programmed cell death induced by death receptor engagement, DNA-damaging agents and endoplasmic reticulum stress. Nur77 overexpression leads to enhanced nuclear factor (NF)-kB activity, which contributes to Nur77 anti-apoptotic activity via induction of the anti-apoptotic gene cIAP1. These results show that cross-talk between Nur77 and other transcription factors contributes to cell-fate decisions in response to different apoptosis-inducing agents. 29 Which factors regulate the switch between the pro-or anti-apoptotic functions of Nur77 remains unclear.
An additional mechanism that links DNA damage and the apoptotic pathway involves Caspase-2. Activation of this protein was shown to occur within PIDDosome, a protein complex that contains PIDD (p53-induced protein with a death domain), an adaptor protein RAIDD (receptor-interacting protein-associated ICH-1 homologous protein with a death domain) and Caspase-2. Increased PIDD expression results in spontaneous activation of Caspase-2 and sensitization to apoptosis induced by genotoxic stimuli. 30 The prodomain of Caspase-2 was shown to be required for its nuclear localization and activation, and further studies demonstrated that nuclear Caspase-2 is rapidly cleaved in cells upon DNA damage.
Caspase-2 deficiency is characterized by increased DNA damage and genomic instability in proliferating cells. Casp2 À / À MEFs readily escape senescence in culture, exhibit increased micronuclei formation and sustained DNA damage during cell culture and following g-irradiation. Loss of caspase-2 leads to defective p53-mediated signaling and decreased transactivation of p53 target genes upon DNA damage. 31 It seems that both p53-dependent and -independent mechanisms can be activated upon DNA damage, leading to apoptosis induction; it might depend on the type of damage as well as the type of cells ( Figure 2 ).
CELL DEATH VIA MC
To maintain genome integrity, cells respond to DNA damage by either a delay in cell-cycle progression, allowing time for proper DNA repair, or by the elimination of cells that are irreparably injured. When checkpoints are compromised, cells can enter mitosis prematurely before the completion of DNA repair and initiate MC. 32 MC occurs either during or shortly after a dysregulated/failed mitosis and can be accompanied by morphological alterations, including micronucleation (which often results from chromosomes and/or chromosome fragments that have not been distributed evenly between the daughter nuclei) and multinucleation (the presence of two or more nuclei of similar or heterogeneous sizes, derived from a deficient separation during cytokinesis). In addition to mitotic failure caused by defective cell-cycle checkpoints, MC can be triggered by agents that influence the stability of microtubules and various anticancer drugs. MC was also described as the main form of cell loss induced by ionizing radiation. How does DNA damage induce MC and what is the link between MC and the cell death machinery?
It is well known that tumors differ in their sensitivity to treatment with DNA-damaging agents. Sensitive cells die during interphase, before entering mitosis. Cells that do not undergo death in interphase may become arrested in G1 and/or G2. If the Severe and irreparable DNA damage evokes senescence or cell death program such as apoptosis, mitotic catastrophe, autophagy and necrosis. p53 has a central role in a complex signal transduction pathway following DNA damage, orchestrating primarily the apoptotic response, and regulates the switch between the apoptosis and cellular senescence. p21 waf1/cip1 is a crucial target of p53 and is also a mediator of senescence. The DNA damage-induced necrosis pathway is mediated mainly by ATP depletion followed by PARP activation. The mitotic catastrophe is initiated when the cell-cycle checkpoints are compromised and cells enter mitosis prematurely before the completion of DNA repair; commonly, it serves as a prestage of apoptosis or necrosis. The final cell death modality in this case depends on the presence/absence of functional p53, caspase-2 and Chk2-related proteins. Cellular context, nature and magnitude of stress are essential for the type of autophagy response: enhancing cell survival or inducing autophagic cell death, having tight cross-talk with the apoptotic pathway. cellular machinery is not able to repair the damage during arrest, some cells can die by apoptosis after one or even several mitotic cycles. In other circumstances, premature mitosis may lead to MC. However, depending on the severity of DNA damage, cells can also exit mitosis to form 4N G1 cells, and after the second arrest at G1, they die or survive. Dying cells are characterized by mitotic abnormalities, such as a multipolar meta-or anaphase, lagging telophase, the random distribution of condensed chromosomes throughout the cells, and so on. The biochemical mechanisms responsible for these differences remain unclear. However, without prematurely entering mitosis, a cell cannot undergo MC. It is important to note that cells that are sensitive to apoptosis and die during interphase have very little or no likelihood of displaying features of MC. There are several experimental models that have been utilized to clarify the biochemical changes associated with MC. Thus, the inability of HCT116 colon carcinoma cells to sequester cyclin B and Cdc2 in the cytoplasm following doxorubicin-induced DNA damage is already a well-established MC model. However, more recent data indicate that Chk2, and not 14-3-3s, may be the main negative regulator of MC in this model. 33 Abrogation of the ATR-initiated checkpoint cascade mediated through Chk1 also directs cells into MC and has been analyzed with respect to specific Chk1 phosphorylations. Other cell-cycle-regulating proteins whose normal function seems to inhibit entry into mitosis are the checkpoint mediators Brca1, p73 and p53. In the absence of p53, cells have the ability to activate alternative routes to halt the cell cycle. One of the proteins that may be involved in this process in addition to Chk1 is p38MAPK (p38 mitogen-activated protein kinase). 34 Depletion of p38MAPK/ MK2 in p53-deficient cells leads to checkpoint deregulation and MC irrespective of the type of DNA damage induced. This two-hit model suggests that MC is the outcome of DNA damage only when multiple central checkpoint proteins are suppressed and other options for cell death and survival are minimized.
One of the most prominent morphological characteristics of MC is the formation of giant cells with abnormal nuclei. 35 Several possible scenarios for the death of giant cells have been suggested. According to one of these, death is a direct cause of MC and is distinct from apoptosis. This conclusion was based on the dissimilarities in morphology between MC and apoptotic cells. Despite their distinct morphology, some authors have suggested that the two processes share several biochemical hallmarks. Thus, following inhibition of Chk2 in syncytia generated by the fusion of asynchronous HeLa cells, metaphase-associated MC was accompanied by sequential Caspase-2 activation, mitochondrial release of pro-apoptotic proteins, activation of Caspase-3, DNA fragmentation and chromatin condensation. 36 However, it has also been reported that dying multinucleated giant cells are characterized by uncondensed chromatin and the absence of DNA ladder formation. 37 It seems that the presence or absence of chromatin condensation during MC depends on different events, including the stage at which mitotic arrest takes place. There is no consensus concerning the requirement of caspases for MC, but it is likely that the progression of MC is caspase-independent as neither inhibition nor down-regulation of caspases influences the appearance of giant cells, although caspases are essential for the termination of MC, suggesting that MC-related morphological changes are followed by activation of the apoptotic machinery. Thus, MC is not an ultimate manifestation of cell death but rather a process leading to apoptosis. 37 Apoptosis, however, is not always required for MC lethality as some giant cells can undergo slow death in a necrosis-like manner. This conclusion is based on similarities between morphological changes during MC and necrosis (the loss of nuclear and plasma membrane integrities). Mitotic arrest in docetaxel-treated tumor cells was followed by massive cell destruction by means of cell lysis. Appearance of multinucleated giant cells that were terminated via a necrosis-like lysis was also observed in a cisplatin-treated ovarian carcinoma cell line, SKOV-3. Necrosis following MC could be an effect of genetic instability caused by aneuploidy and/or polyploidy (Figure 2 ).
Detailed analysis of the morphological markers associated with MC revealed that this process can also precede or occur in parallel with cell senescence (a persistent arrest in the G1 phase of the cell cycle that manifests with cell flattening, increased b-galactosidase activity and decreased telomerase function). 38 Taken together, it is important to note that cells facing a mitotic-linked cell death can, in fact, die by two separate mechanisms, either by apoptosis or necrosis, depending on the molecular profile of the cell, or undergo senescence. Accordingly, the disruption of MC blocks cancer progression, and its induction might constitute a therapeutic endpoint. 38 Mitotic catastrophe was long ago described to occur in response to DNA damage; however, it is still remains unclear how to modulate this process to favor different cell death outcomes. Induction of MC as a possible anti-cancer treatment needs to be further evaluated, and more in vivo work is required in order to define the critical modulating factors.
DNA DAMAGE AND AUTOPHAGY
Autophagy is a well-known evolutionarily conserved catabolic program for the degradation of proteins and other subcellular elements through lysosomal proteolysis. In most cases, autophagy serves as a pro-survival mechanism, which adapts cells to stress conditions by providing metabolic precursors for cellular renewal and maintenance through the recycling of cellular components. On the other hand, substantial activation of autophagy in response to stress can lead to cell death. The cellular outcome of inducing autophagy in response to stress is complex and depends on the cellular context, type and magnitude of stress. In mild stress conditions, autophagy may enhance cell survival by allowing the cell to engage repair mechanisms and checkpoint activation; higher levels of damage over a prolonged period of time may trigger autophagic cell death, also known as type II programmed cell death.
The typical DNA-damaging compounds 6-thioguanine and 5-fluorouracil were shown to induce autophagy. An important role in this process was suggested for BNIP3 (Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3), which mediates autophagy in a p53-and mTOR (mammalian target of rapamycin)-dependent manner. 39 Although the mechanisms of p53-dependent induction of autophagy remain incompletely understood, there are indications that both transcription-dependent (upregulation of mTOR inhibitors, PTEN (phosphatase and tensin homolog) and TSC1 (tuberous sclerosis protein 1) or DRAM (damage-regulated aautophagy modifier)) and -independent pathways (AMPK (5 0 adenosine monophosphate-activated protein kinase) activation) are involved. 40, 41 Interestingly, p53-induced autophagy may lead to cell death, and this can be blocked by DRAM small interfering RNA. However, under some circumstances, such as in c-Myc-driven lymphomas, p53-mediated autophagy can actually promote cell survival, as inhibition of autophagosomal maturation enhances p53-mediated tumor cell death. Thus, p53-mediated autophagy can affect both life and death decisions depending on the cell type or type of stimulus, and it reflects the activation of different sets of p53 signals (Figure 2 ). It is important to note that the role of p53 as a positive regulator of autophagy has been questioned by some authors. In particular, deletion, depletion or inhibition of p53 was shown to induce autophagy in human, mouse and nematode cells. Inhibition of p53 led to autophagy in anucleated cells, and cytoplasmic, not nuclear, p53 is believed to repress the enhanced autophagy of p53 À / À cells. 42 Overall, the opposing control of autophagy by p53 raises many important questions for future research.
Recent data described a new cytoplasmic pathway linking ATM and autophagy, suggesting that ATM can engage the TSC2/ mTORC1 signaling pathway in order to regulate autophagy ( Figure 1) . Even though the molecular mechanisms regulating this phenomenon are not clear, it was indicated that a substantial cytoplasmic pool of ATM is phosphorylated in the presence of leptomycin B and could initiate signaling via LKB1 (Serine/ threonine kinase 11), AMPK and TSC2 in the cytoplasm to suppress mTORC1, resulting in an increased autophagic flux. 43 Poly ADP-ribose polymerase (PARP) has also been implicated in the cell's decision to commit to autophagy following DNA injury. Studies using PARP-1 wild-type and deficient cells revealed the formation of autophagic vesicles and the increased expression of genes involved in autophagy (bnip-3, cathepsin b and beclin 1) in wild-type cells treated with doxorubicin but not in PARP À / À cells or cells treated with a PARP inhibitor. 44 New insights into how PARP-1 could have a role in the cell's decision to undergo autophagy and how it determines the cytotoxic effect to DNA damage have been described. The results indicate that doxorubicin induces PARP-1 hyperactivation in immortalized MEFs, leading to a cell response with two components: cell death with characteristics of necrosis and autophagy, with a cytoprotective effect. Authors imply that cellular energy collapse (derived from PARP-1 overactivation) is a key event in the cell's decision to commit autophagy. 44 Interestingly, recent data suggest that cells may use specific autophagy subpathways rather than recycle all the cellular components, including those that are not damaged. It was proposed that two yeast histone deacetylases Rpd3 and Hda1, and the acetyltransferase Gcn5, control chromosome stability by coordinating the ATR checkpoint and DSB processing with autophagy. 45 Upon DSB formation, Rpd3 and Hda1 keep Sae2 (human CtIP (C-terminal-binding protein interacting protein)) in the deacetylated form, which influences Mre11 dynamics at the DSB site. Sae2 is then released from the DSB site, perhaps in a multimeric form, and Gcn5-mediated acetylation shunts it into autophagy-mediated degradation. This last step might be needed to counteract extensive DSB resection and/or simply to eliminate Sae2 once the first step of DSB processing has been accomplished.
Depending on the stimulus and cellular context, autophagy may be a prerequisite for apoptosis by preceding and later turning it on. On the other hand, there are some circumstances in which autophagy may antagonize or delay apoptosis, or in which these two processes may act exclusively and serve as reciprocal backup mechanisms. Although it has become clear that cell fate in response to stress, including DNA damage, can be determined by the functional status and the interaction between apoptosis and autophagy, the precise mechanisms underlying this switch between these two stress-mitigating pathways remain obscure (Figure 2 ). Resistance to apoptosis is believed to increase the possibility that cells may undergo autophagic cell death in response to chemotherapy and irradiation, promoting an alternative pathway for drugs and irradiation to facilitate tumor cell killing. Studies of double-knockout MEFs indicate that after treatment with etoposide, Bax À / À Bak À / À MEFs fail to undergo apoptosis and exhibit massive autophagy followed by delayed cell death. Elimination of the autophagy gene products Beclin-1 and Atg5 was also shown to reduce the etoposide-induced cell death in the same MEFs. In this cellular setting, no autophagy was induced when apoptosis was inhibited by other perturbations, such as Apaf-1 À / À and caspase-9 À / À MEFs, or the addition of the caspase inhibitor zVAD-fmk to wild-type MEFs. 46 This could imply that Bcl-2-family proteins, such as Bax and Bak, may have direct or indirect roles in regulating autophagy that are independent of their role in modulating apoptosis. Furthermore, PUMA, a key mediator of p53-dependent apoptosis, was found to induce autophagy that leads to the selective removal of mitochondria. The study suggested that under some circumstances the selective targeting of mitochondria for autophagy can enhance apoptosis, as inhibition of PUMA or Bax-induced autophagy leads to a reduced apoptotic response. 47 There is an interesting link between the p53 and JNK signaling pathways in terms of the regulation of autophagy. Ewing sarcoma cells treated with 2-methoxyestradiol (2-ME) are characterized by enhanced autophagy and apoptosis occurring by the activation of both the p53 and JNK pathways. In this context, p53 regulates, at least partially, JNK activation, which in turn modulates autophagy via two distinct mechanisms: the promotion of Bcl-2 phosphorylation, resulting in the dissociation of the Beclin 1-Bcl-2 complex, and the upregulation of DRAM. The critical role of DRAM in 2-ME-mediated autophagy and apoptosis is underlined by the fact that its silencing efficiently prevents the induction of both the processes. 48 Overall, many important questions concerning cross-talk between apoptosis and autophagy remain to be addressed, and the most significant involves identifying the exact biochemical switches that direct a cell towards apoptosis or autophagy.
REGULATED FORM OF NECROTIC CELL DEATH INDUCED BY DNA DAMAGE
Necrosis is an acute form of cell death usually initiated following energy loss. Until recently, necrosis was considered to be an unregulated form of cell death; however, accumulating experimental data demonstrate that, except under extreme conditions, necrosis may be a genetically regulated process. Poly(ADPribosyl)ation was shown to have a central role in modulating the cellular response to severe genotoxic stress and induction of cell death through necrotic mechanisms. Among the targets of PARP are various proteins that are involved in DNA damage checkpoints, including p53, p21 waf1 , XPA (xeroderma pigmentosum group A), MSH6, DNA ligase III, XRCC1, DNA polymerase-e, DNA-PK CS , Ku70, NF-kB, iNOS (inducible nitric oxide synthase), caspaseactivated DNase and telomerase. 49 Because of the high negative charge on ADP-ribose polymers, poly-ADP-ribosylated proteins lose their affinity for DNA and, as a consequence, their biological activities. ATP depletion is the central mechanism by which PARP activation is suggested to participate in DNA damage-induced necrotic death. PARP À / À fibroblasts resist necrotic death induced by MNNG (N-methyl-N'-nitro-N-nitrosoguanidine), and PARP À / À mice resist necrotic death during hemorrhagic shock. In thymocytes, kidney and pulmonary artery, PARP inhibitors also prevent necrotic, but not apoptotic, cell death induced by oxidants. 50, 51 Cleavage of PARP by caspases at a single site occurs at an early stage of apoptosis and can be blocked by caspase inhibitors or Bcl-2 overexpression, suggesting that the loss of PARP function is required for efficient accomplishment of apoptosis. 52 Caspase-mediated PARP cleavage promotes apoptosis due to the essential reduction of its repair function, thus preventing unnecessary DNA repair and also facilitating the access of endonucleases to chromatin. Caspase inhibition is known to cause a switch from apoptosis to necrosis, suggesting that the induction of apoptosis is a protective mechanism against necrotic damage (Figure 2) .
Some experimental data propose a role of poly(ADP-ribose) and PARP in p53-mediated pathways upon DNA damage, although opinions concerning the interaction of these two components are controversial. Studies of splenocytes, bone marrow cells and embryonic fibroblasts from PARP À / À mice showed an increase in p53 accumulation after treatment with an alkylating agent. 53 X-ray-induced accumulation of p53 was found to increase upon PARP inhibition. It has been established that the PARP inhibitor 3-aminobenzamide delays the repair of both SSBs and DSBs caused by ionizing radiation and that cells treated with inhibitor immediately after X-ray irradiation exhibit a prolonged p53 response. Later studies suggested that inactivation of PARP affects the duration, but not the magnitude, of p53 accumulation in irradiated Burkett lymphoma cells. p53 accumulation is controlled by PARP-dependent and PARP-independent pathways, but p53 activation is largely independent of PARP. It has also been reported that the activity of DNA-PK can be stimulated by PARP in the presence of NAD þ in in vitro reactions and that DNA-PK ADPribosylation stimulates p53 phosphorylation. 54 Hence, the role of PARP in p53 activation is complex, involving not only direct activation, but also by acting through DNA-PK and possibly other proteins to transmit the DNA damage signal to p53. Overall, the current data suggest a passive rather than an active role of PARP in the apoptotic process.
Energy collapse is not the sole mechanism by which PARP contributes to cell death. A 'death link' between PARP, mitochondria and AIF (apoptosis-inducing factor) has been established. AIF is a bifunctional NADH (nicotinamide adenine dinucleotide phosphate-oxidase) oxidase that has both a pro-survival role through its yet unknown activity in mitochondria, and a lethal role upon its translocation to the nucleus. Once translocated to the nucleus, AIF is involved in chromatinolysis and cell death. In order to be released from mitochondria, AIF has to be cleaved into tAIF by calpain or cathepsins. 55, 56 The proteolytic process is Ca 2 þ -dependent, and in addition to a sustained intracellular Ca 2 þ elevation, enhanced formation of ROS is a prerequisite step for AIF to be cleaved and released from mitochondria. The stimulated ROS production leads to oxidative modification (carbonylation) of AIF, which markedly increases its rate of cleavage by calpain. Combined, these data provide evidence that ROS-mediated, posttranslational modification of AIF is critical for its cleavage by calpain and, thus, for AIF-mediated cell death. 57 Recent data indicate that PARP activation is required for AIF translocation during cell death initiated by MNNG and H 2 O 2 in fibroblasts and NMDA (N-methyl-D-aspartic acid) in cortical neurons. Moreover, AIF appears to be essential for PARP-1-mediated cell death. It was also demonstrated that tAIF release depends on PARP-1-mediated calpain and Bax activation. 58 The critical role of PARP in controlling AIF-mediated cell death is further supported by observations that NMDA-induced AIF translocation and cell death are blocked in neurons derived from PARP-null mice as well as in wild-type neurons in the presence of the pharmacological PARP inhibitor DPQ. Studies on isolated mouse liver mitochondria and HeLa cells showed that AIF activity is maintained in the presence of the caspase inhibitor zVAD-fmk. Therefore, death mediated by PARPactivation and translocation of AIF are examples of caspaseindependent cell death.
Although a number of studies have shown the ability of PARP to regulate AIF translocation following different cytotoxic stimuli and in different cell types, very little is known about the precise mechanism by which AIF mediates DNA fragmentation upon its translocation to the nucleus and ultimately to the execution of cell death. Examination of the AIF crystal structure has demonstrated that AIF can bind DNA in a sequence-independent manner. Structure-based mutagenesis revealed that DNAbinding defective mutants of AIF fail to induce cell death while retaining nuclear translocation. AIF-interacting partners, as well as components that promote nuclear chromatin breakdown in mammalian cells, remain to be identified. The observation that AIF associates with histone H2AX in the nucleus via the C-terminal proline-rich binding domain suggests that this interaction regulates chromatinolysis and programmed necrosis by generating an active DNA-degrading complex with cyclophilin A. The data obtained demonstrated that AIF fails to induce chromatinolysis in H2AX-or cyclophilin A-deficient nuclei. 59 Although these data shed new light on the mechanisms regulating programmed necrosis, additional studies are needed to elucidate the key nuclear partner of AIF and clarify its mechanism of action in the nucleus.
CROSS-TALK BETWEEN DIFFERENT CELL DEATH MODALITIES UPON DNA DAMAGE AND ITS APPLICATION FOR THERAPY
As previously described, DNA damage elicits various cellular responses and can lead to the execution of programmed cell death via different molecular mechanisms. However, there is still a gap in our knowledge about what defines these distinct death fates upon genotoxic stress. It is generally appreciated that the extent of DNA damage significantly influences the cell fate. Some studies support the hypothesis that the nature of the DNA lesion also has a major impact on cell fate at comparable cytotoxic doses. For instance, the apoptotic cell death response triggered by different DNA lesions may differ qualitatively and quantitatively. Two DNA-damaging drugs, adozelesin and bizelesin, are known to produce similar DNA lesions (alkylation) and their cytotoxic effect is mediated by both G2-M cell-cycle arrest and cell death. 60 Despite these similarities, the drugs were shown to trigger qualitatively distinct cell death pathways in HCT116 colon carcinoma cells: adozelesin-induced cell death was associated with greater caspase activation than bizelesin-induced death. A low cytotoxic dose of adozelesin induced much more caspase activity than a higher dose of bizelesin. Another drug C-1027, which is a radiomimetic compound that interacts with DNA and induces SSBs and DSBs, or abasic sites by free radical attack of deoxyribose moieties, was shown to induce apoptotic cell death without triggering caspase activation.
Another important determinant of the cell death mode following DNA damage is the genetic status of the cell and the profile of proteins involved in the regulation of the cell cycle. For example, the presence of p53 has a central role in DNA damageinduced cell death, but in the absence of functional p53 delayed death referred to as MC can occur. We have previously shown that in the presence of p53 ovarian carcinoma cells treated with cisplatin undergo apoptosis and that nuclear Caspase-2 is translocated to the cytosol during this process. By contrast, the absence of p53 led to MC followed by necrosis-like lysis without involvement of Caspase-2. Further, Chk2 inhibition in cells expressing p53 triggers MC in response to DNA damage. However, at later time points these cells undergo apoptosis (Figure 2 ). 61 Two conceptual models for how the death response to DNA damage is regulated were proposed by Borges et al. 62 and termed as the 'integrative surveillance' and 'autonomous pathways'. The 'integrative surveillance' concept states that cells die when the DNA damage is irreparable, which is consistent with most of the published data on cellular responses to DNA damage and is widely accepted. Nevertheless, there is still no clear evidence of an irreparable DNA lesion or exact biochemical mechanism for how the DNA damage signaling network can discriminate between reparable versus non-reparable DNA lesions. Yet, the integrative suveillance model has remained a reasonable, and seldom challenged, explanation for when and how a damaged cell may choose to commit suicide. In the alternative concept, termed 'autonomous pathways', the DNA damage signaling network activates DNA repair and cell death simultaneously and automatically, but the onset of cell death is delayed. 63 One of the proposed explanations is that new gene expression might be required for the execution of cell death, and, as accumulation of RNA transcripts and protein products naturally takes time, the death response is delayed. The second possibility is that delay occurs due to built-in feedback loops in the death response pathways, so that death occurs only if the negative feedback is overridden. The third possibility involves a requirement for positive feed-forward loops to raise the death signals above a threshold that can overcome existing survival signals. Thus, in this model, death is a delayed response that correlates with the persistence of DNA damage. 62 Overall, as mentioned above, p53 has a central role in a complex signal transduction pathway following DNA damage, regulating the switch between the processes of apoptosis and cellular senescence. Additionally, cell type appears to be the crucial determinant in this process. It is important to note that senescence can be triggered by much lower stress levels than apoptosis. Some studies point to a cross-talk between apoptosis and cellular senescence, for instance at the level of the anti-apoptotic protein Bcl-2. Overexpression of Bcl-2 in E1A þ ras-transformed rodent fibroblasts in a p38-dependent manner promotes cell-cycle arrest after irradiation and accelerates senescence after doxorubicin treatment. 64 Caspase inhibition was shown to cause an increased expression of p21 waf1 and switch the doxorubicin-induced apoptosis to senescence in human neuroblastoma SKN-SH cells. 65 Nevertheless, the crossregulation between apoptosis and cellular senescence is far from being completely understood. The relationship between autophagy, senescence and apoptosis is even more complex and again involves the tumor-suppressor protein p53 as a master regulator of switches between these processes, as described above. Some studies reported that autophagy is induced during and facilitates senescence or limits damage and delays apoptosis to allow recovery of normal cell function. 66, 67 In general terms, similar stimuli can induce either apoptosis or autophagy, and decisions can be made by the cell perhaps depending on the variable thresholds for both processes. Autophagy can occur when apoptosis is inhibited, which was shown, for example, in the studies on Bak-and Bax-deficient cells, and vice versa inhibition of autophagy may lead to apoptosis. It was shown that autophagy delays apoptotic death in breast cancer cells following DNA damage, and downregulation of autophagy proteins, Beclin 1 and Atg7, unmasked a caspase-dependent apoptotic response in MCF-7 cells upon camptothecin exposure. 68 Recent findings in nonsmall cell lung carcinoma (NSCLC) cells suggest that autophagy suppression leads to inhibition of NSCLC cell proliferation and sensitizes them to cisplatin-induced caspase-dependent andindependent apoptosis by stimulation of ROS formation. 69 Interestingly, Atg3, an essential regulatory component of autophagosome biogenesis, was identified as a new substrate for Caspase-8 during receptor-mediated cell death, providing a novel link between apoptosis and autophagy. 70 Although the link between autophagy and apoptosis has been studied to some extent, the link between autophagy and necrosis is remaining unclear. In Caenorhabditis elegans, autophagy was shown to be required for the necrotic breakdown of nematode neurons. Moreover, this work provided evidence that excessive autophagy is induced by necrotic cell death, and it showed that autophagy and lysosomal proteolysis combine to promote cell demise. 71 On the other hand, there are some data indicating that in apoptosis-defective cells inactivation of autophagy promotes necrotic cell death in vitro and in tumors in vivo. 72 Yet, the interplay between necrosis and autophagy upon DNA damage remains to be investigated in more detail.
Thus, depending on the conditions of DNA injury, the different cellular death outcomes can substitute for each other, which is important to ensure the elimination of the cells in case the damage cannot be resolved (Figure 2 ). Both senescence and apoptosis are important tumor-suppressor mechanisms. Additionally, autophagy and MC induced by drugs now are considered to make important contributions to the overall loss of tumor cell viability. It should be also noted that each type of cellular response can result in a very different clonogenic potential. So, understanding the complexity of the DDR and the mechanisms responsible for various cell deaths, as well as viewing cellular responses as coordinated interplay of various competing pathways, can open new possibilities to modulate the responses of cells to different DNA-damaging effectors as well as to predict the cytotoxic therapy outcomes both in normal and cancer cells. By choosing the corresponding doses and agents, we can favor different cellular outcomes; this requires the development of new in vivo assessment methods. Advances in the understanding of such complex cell death interplay can be applied, for instance, in a newly proposed concept in cancer therapy called the concept of synthetic lethality. 73 According to this concept, the synthetic lethal interactions can be defined as two genetic alterations that occur in cancer cells and cause cell death when occurring together, while neither mutation alone is lethal. In other words, some changes in the signaling pathways of cancer cells can be considered as sensitizing mutations if they make transformed cells dependent on certain molecules or pathway combinations for survival and are not necessary in normal cells. Thus, such molecular changes provide excellent therapeutic opportunities if combinations of these pathway can be selectively targeted. This approach can be used to enhance the effects of DNA-damaging agents. It would be interesting to explore the possibility to modulate the cell death response and switch between different modes to favor a desirable outcome in response to genotoxic stimuli applying the synthetic lethality concept. The potential of such a strategy has to be addressed in further studies.
CONCLUDING REMARKS
Accumulating evidence supports the notion that, depending on the severity of treatment in response to DNA damage, cells either can repair the injury and survive normally or, in the case of inefficient repair, they still can survive while carrying the mutation or die. The cell death modality also depends on the severity of DNA damage as well as expression of various proteins, which are involved in the regulation of different cell death programs. The molecular basis underlying the cross-talk between these programs is currently the subject of intense investigation. Although interaction between some genes and their products essential for the switch was described above, there are still many gaps that should be fulfilled to shed full light on this complex process. This knowledge is important for exploring the possibility to modulate the cell death response and switch between different modes to favor desirable outcomes in response to DNA damage. The characterization and understanding of complex DDR signaling together with finding new targets for engagement of various cell death pathways would help us to guide the response to DNA injury from upstream sensors to favorable downstream response outcomes. This would not only help researchers learn more about the cellular fate after genotoxic insults but more importantly to uncover basic mechanisms of how viable and healthy cells recognize signals and respond by committing to cell death. Presently, we have entered the era of developing new pharmaceuticals that target DNA in order to kill tumor cells and, therefore, the clinical advantage as well as the potential adverse effects of such therapy must be critically evaluated.
